Paroxysmal Nocturnal Hemoglobinuria
📧 Sign up to get email alerts when something new happens for Paroxysmal Nocturnal Hemoglobinuria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-01-29Clinical Trial Update: Stem Cell Transplantation for Patients With Hematologic Malignancies [Phase 3]
A Phase 3 clinical trial evaluating stem cell transplantation for hematologic malignancies has completed. The study covered several conditio…
-
CLINICAL_TRIALS trial_result · 2009-01-29Clinical Trial Update: Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies [Phase 2]
Phase 2 clinical trial update on stem cell transplantation as immunotherapy for hematologic malignancies. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria [Phase 3]
This update notes the completion of a Phase 3 trial evaluating eculizumab (Soliris) for paroxysmal nocturnal hemoglobinuria.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria
A completed NHLBI-sponsored clinical trial evaluating the transfer of GPI-linked proteins to transfused patients with paroxysmal nocturnal h…
-
CLINICAL_TRIALS trial_result · 2007-02-21Clinical Trial Update: Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab [Phase 3]
A Phase 3 trial evaluated the safety of eculizumab in patients with paroxysmal nocturnal hemoglobinuria. The study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2006-12-04Clinical Trial Update: Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients [Phase 3]
A Phase 3 study evaluating eculizumab in transfusion-dependent paroxysmal nocturnal hemoglobinuria has completed.